alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 32**

 

**CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND**

**CHIEF FINANCIAL OFFICER**

**Pursuant to 18 United States Code § 1350,**

**as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002**

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Leonard F. Leganza, the Chief Executive Officer of The Eastern Company (the “Company”) and John L. Sullivan III, the Chief Financial Officer of the Company, hereby certify that, to the best of their knowledge:

 

| 1) | The Company’s Annual Report on Form 10-K for the period ended December 29, 2007, and to which this certification is attached as Exhibit 32 (the “Periodic Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

| 2) | The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

 

In Witness Whereof, the undersigned have set their hands hereto as of the 11th day of March, 2008.

 

|   | /s/ Leonard F. Leganza |
|--------|------------------------|

|   | Leonard F. Leganza |
|--------|--------------------|

|   | CEO |
|--------|-----|

 

 

|   | /s/ John L. Sullivan III |
|--------|--------------------------|

|   | John L. Sullivan III |
|--------|----------------------|

|   | CFO |
|--------|-----|

 

 

A signed original of this written statement required by Section 906 has been provided to The Eastern Company and will be retained by The Eastern Company and furnished to the Securities and Exchange Commission or its staff upon request. 

 

This certification “accompanies” the Form 10-K to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K, irrespective of any general incorporation language contained in such filing.) 

 

 

 

 

 

 

 

66
Exhibit 32.1
Form 10-QSB
Viking Systems, Inc.
File No. 000-49636

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In  connection  with the  Quarterly  Report of Viking  Systems,  Inc.  (the
"Company") on Form 10-Q for the quarter  ended  September 30, 2003 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Thomas B. Marsh, Chief Executive Officer and President of the Company,  certify,
pursuant to 18 U.S.C.  section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

     (1) the Report fully  complies  with the  requirements  of Section 13(a) or
15(d)of the Securities Exchange Act of 1934; and

     (2)  the  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

Dated:  January 8, 2004



/s/ Thomas B. Marsh
Chief Executive Officer, President
No. 10-6812.

#### Oscar Solis Vela, Petitioner v. Texas.

562 U.S. 1093, 131 S. Ct. 800,

2010 U.S. LEXIS 9513.

178 L. Ed. 2d 535,

December 6, 2010.

Petition for writ of certiorari to the Court of Criminal Appeals of Texas denied.
No. 10-7616.

#### Kenneth Lee Martinez, Petitioner v. Roseanne Campbell, Warden, et al.

562 U.S. 1202, 131 S. Ct. 1048,

178 L. Ed. 2d 868,

2011 U.S. LEXIS 1029.

January 24, 2011.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
ENVIRONMENTAL PROTECTION AGENCY 40 CFR Parts 52 

### [EPA-R06-0AR-2008-0192; FRL- 

### .l Approval and Promulgation of Implementation Plans; Texas; Revisions to Chapter 116 which relate to the Permit Renewal Application and Permit Renewal Submittal

AGENCY: Environmental Protection Agency (EPA).
ACTION: Proposed rule.
SUMMARY: EPA is proposing to approve revisions to the applicable State Implementation Plan (SIP) for the State ofTexas which relate to the Permit Renewal Application and Permit Renewal Submittal regulations. These portions ofthe SIP revisions approved today would address requirements related to the timeline for the submittal ofan application for permit renewal. EPA finds 

### thatthese changes to the Texas SIP comply with the Federal Clean Air Act (the Act or CAA) and EPA regulations, are consistent with EPA policies, and will improve air quality. This action is being proposed under section 110 and parts C and D ofthe Act.
DATES: Comments must be received on or before [insert the date 30 days after date of publication in FEDERAL REGISTER].2



### ADDRESSES: Comments may bemailedtoMr.leffRobinson.Chief. Air Permits Section (6PD-R), Environmental Protection Agency, 1445 Ross Avenue, Suite 1200, Dallas, Texas 75202-2733. Comments may also be submitted electronically or through hand delivery/courier by following the detailed instructions in the 

### ADDRESSES section ofthe direct final rule located in the rules section ofthis 

### Federal Register.

FOR FURTHER INFORMATION CONTACT: Ifyou have questions concerning today's proposal, please contact Ms. Melanie Magee (6PD-R), Air Permits Section, Environmental Protection Agency, Region 6, 1445 Ross Avenue (6PD-R), Suite 1200, Dallas, TX 75202-2733. The telephone number is (214) 665-7161. Ms. Magee can also be reached via electronic mail at magee.melanie@epa.gov.



### SUPPLEMENTARY INFORMATION: In the final rules section ofthis 

### Federal Register, EPA is approving the State's SIP submittal as a direct final rule without prior proposal because the Agency views this as a noncontroversial submittal and anticipates no relevant adverse comments. A detailed rationale for the approval is set forth in the direct final rule. Ifno relevant adverse comments are received in response to this action, no further activity is contemplated. If EPA receives relevant adverse comments, the direct final rule will be withdrawn and all public comments received will be addressed in a subsequent final rule based on this proposed rule. EPA will not institute a second comment period. Any parties interested in commenting on this

### 3 action should do so at this time. Please note that ifEPA receives adverse comment on an amendment, paragraph, or section ofthe rule, and ifthat provision may be severed from the remainder ofthe rule, EPA may adopt as final those provisions ofthe rule that are not the subject of an adverse comment.

For additional information, see the direct final rule which is located in the rules section of this Federal Register.

Dated: Al Armendariz, Regional Administrator, Region 6.
[Federal Register Volume 63, Number 130 (Wednesday, July 8, 1998)]
[Notices]
[Pages 36964-36965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-17995]


-----------------------------------------------------------------------

NATIONAL FOUNDATION ON THE ARTS AND THE HUMANITIES

National Endowment for the Arts


Combined Arts Panel

    Pursuant to Section 10(a)(2) of the Federal Advisory Committee Act 
(Pub. L. 92-463), as amended, notice is hereby given that a meeting of 
the Combined Arts Panel, Multidisciplinary Section (Planning & 
Stabilization category) to the National Council on the Arts will be 
held on August 4-5, 1998. The panel will meet from 9:00 a.m. to 5:30 
p.m. on August 4 and from 9:00 a.m. to 4:30 p.m. on August 5, in Room 
716 at the Nancy Hanks Center, 1100 Pennsylvania Avenue, NW, 
Washington, DC, 20506. A portion of this meeting, from 11:00 a.m. to 
12:30 p.m. on August 5, will be open to the public for a policy 
discussion on field issues and needs, Leadership Initiatives, 
Millennium projects, and guidelines.
    The remaining portions of this meeting, from 9:00 a.m. to 5:30 p.m. 
on August 4 and from 12:30 p.m. to 4:30 p.m. on August 5, are for the 
purpose of Panel review, discussion, evaluation, and recommendation on 
applications for financial assistance under the National Foundation on 
the Arts and the Humanities Act of 1965, as amended,

[[Page 36965]]

including information given in confidence to the agency by grant 
applicants. In accordance with the determination of the Chairman of May 
14, 1998, these sessions will be closed to the public pursuant to 
subsection (c)(4), (6) and (9)(B) of section 552b of Title 5, United 
States Code.
    Any person may observe meetings, or portions thereof, of advisory 
panels which are open to the public, and, if time allows, may be 
permitted to participate in the panel's discussions at the discretion 
of the panel chairman and with the approval of the full-time Federal 
employee in attendance.
    If you need special accommodations due to a disability, please 
contact the Office of AccessAbility, National Endowment for the Arts, 
1100 Pennsylvania Avenue, NW, Washington, DC 20506, 202/682-5532, TDY-
TDD 202/682-5496, at least seven (7) days prior to the meeting.
    Further information with reference to this meeting can be obtained 
from Ms. Kathy Plowitz-Worden, Office of Guidelines & Panel Operations, 
National Endowment for the Arts, Washington, DC 20506, or call 202/682-
5691.

    Dated: July 1, 1998.
Kathy Plowitz-Worden,
Panel Coordinator, Panel Operations, National Endowment for the Arts.
[FR Doc. 98-17995 Filed 7-7-98; 8:45 am]
BILLING CODE 7537-01-M
<PAGE>

                                                                   EXHIBIT 32.01

                              THE BANC CORPORATION
                   CERTIFICATION OF PERIODIC FINANCIAL REPORT
                       PURSUANT TO 18 U.S.C. SECTION 1350

      Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, the undersigned officer of The Banc Corporation
(the "Company") certifies that, to his knowledge, the Quarterly Report on Form
10-Q of the Company for the Quarter ended March 31, 2006, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the
Company.

Dated:  May 10, 2006                    /s/ C. Stanley Bailey
                                        ---------------------------
                                           C. Stanley Bailey
                                           Chief Executive Officer

A signed original of this written statement required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
# C_2016475EN.01001401.xml

| 19.12.2016 | EN | Official Journal of the European Union | C 475/14 |
| --- | --- | --- | --- |

19.12.2016

EN

Official Journal of the European Union

C 475/14

---

Order of the President of the Ninth Chamber of the Court of 22 September 2016 (request for a preliminary ruling from the Tribunalul Sibiu — Romania) — Nicolae Ilie Nicula v Administrația Județeană a Finanțelor Publice Sibiu formerly Administraţia Finanţelor Publice a Municipiului Sibiu, Administrația Fondului pentru Mediu, intervener: Cristina Lenuța Stoica

(Case C-609/14) (1)

1

(2016/C 475/20)

Language of the case: Romanian

The President of the Ninth Chamber has ordered that the case be removed from the register.

---

(1)  OJ C 107, 30.3.2015.

1

---
Exhibit 32


                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Sunburst Acquisitions VII, Inc.
(the "Company") on Form  10-QSB  for the period ending  September 30, 2004
(the "Report"),  I, Jay Lutsky,  Principal  Executive  Officer of  the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906  of the Sarbanes-Oxley Act of  2002, that:

1) The Report fully complies with the requirement of Section 13(a) or 15 (d)
of the Securities Exchange Act of 1934; and

2) The information contained in the  Report fairly presents, in all material
respects, the Company's financial position and results of operations.



/s/ Jay Lutsky
-----------------------
Principal Executive Officer
November 8, 2005
exv10w12



 





Exhibit 10.12




Rochester Medical Corporation

Fiscal 2005 Executive Compensation Plan




(adopted by the Compensation Committee of the Board of Directors on November 18, 2004)




MANAGEMENT INCENTIVE PLAN (BONUS)




Eligibility





	•	 	All Executive Officers and Director level management personnel will be
eligible to participate.
	 
	•	 	Recommended participation rates have been set by the President, and
are based upon the respective position level and function of each
executive. In all cases, participation rates are well within
competitive incentive compensation ranges.




Fiscal 2005




	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	Bonus Participation	 	Weighted Performance
	 	 	(% of Base Salary)
	 	Criteria

	 	 	Minimum	 	Target	 	Maximum	 	 	 	 	 	Operating
	Participant
	 	Payout
	 	Payout
	 	Payout
	 	Sales
	 	Income

	Conway, Jim
	 	 	0	%	 	 	35	%	 	 	52.5	%	 	 	50	%	 	 	50	%
	Conway, Philip
	 	 	0	%	 	 	25	%	 	 	37.5	%	 	 	50	%	 	 	50	%
	Horner, Dara Lynn
	 	 	0	%	 	 	25	%	 	 	37.5	%	 	 	50	%	 	 	50	%
	Jonas, David
	 	 	0	%	 	 	25	%	 	 	37.5	%	 	 	50	%	 	 	50	%
	Sholtis, Martin
	 	 	0	%	 	 	25	%	 	 	37.5	%	 	 	75	%	 	 	25	%
	Anglin, Robert
	 	 	0	%	 	 	20	%	 	 	30	%	 	 	50	%	 	 	50	%








	•	 	The sales and operating income performance targets shall be set and
approved annually by the Compensation Committee.




Bonus Calculation and Payout




     The President will evaluate actual results from the respective areas of
responsibility for each executive against financial targets. This evaluation
will result in a recommended payout level as a percentage of the annual
incentive target. Performance levels and recommended payouts will be reviewed
and approved by the Compensation Committee prior to disbursement.
<PAGE>

                                                                      Exhibit 32


(a)      Certification by President of Quarterly Report

                       CERTIFICATION OF QUARTERLY REPORT

I, Robert B. Kay, President of Key Components, LLC and Key Components Finance
Corp. (collectively, the "Company"), certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)      The Quarterly Report on Form 10-Q of the Company for the period ended
         March 31, 2004 (the "Report") fully complies with the requirements of
         Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15
         U.S.C. 78m or 78o(d)); and

(2)      the information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.

Date: May 17, 2004


/s/ Robert B. Kay
------------------------------
Robert B. Kay
President


                                       28
<PAGE>

(b)      Certification by Chief Financial Officer of Quarterly Report

                       CERTIFICATION OF QUARTERLY REPORT

I, Keith A. McGowan, Chief Financial Officer of Key Components, LLC and Key
Components Finance Corp. (collectively, the "Company"), certify, pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)      The Quarterly Report on Form 10-Q of the Company for the period ended
         March 31, 2004 (the "Report") fully complies with the requirements of
         Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15
         U.S.C. 78m or 78o(d)); and

(2)      the information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.


Date: May 17, 2004


/s/ Keith A. McGowan
------------------------------
Keith A. McGowan
Chief Financial Officer


                                       29
I 

116TH CONGRESS 

1ST SESSION H. R. 2876 

To direct the Secretary of State to make available to the Director of the 

Centers for Disease Control and Prevention copies of consular reports 

of death of United States citizens, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

MAY 21, 2019 

Mr. SEAN PATRICK MALONEY of New York introduced the following bill; 

which was referred to the Committee on Energy and Commerce, and in 

addition to the Committee on Foreign Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such 

provisions as fall within the jurisdiction of the committee concerned 

A BILL 

To direct the Secretary of State to make available to the 

Director of the Centers for Disease Control and Prevention copies of consular reports of death of United States 

citizens, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘American Students 

5 Abroad Act’’. 


kjohnson on DSK79L0C42 with BILLS
2 

•HR 2876 IH

1 SEC. 2. COPIES OF CONSULAR REPORTS OF DEATH OF U.S. 

2 CITIZENS ABROAD TO BE MADE AVAILABLE 

3 TO THE CENTERS FOR DISEASE CONTROL 

4 AND PREVENTION. 

5 (a) IN GENERAL.—The Secretary of State shall make 

6 available to the Director of the Centers for Disease Con7 trol and Prevention for each calendar quarter a copy of 

8 each report described in subsection (b) that is issued dur9 ing the preceding calendar quarter. 

10 (b) REPORT DESCRIBED.—The report described in 

11 this subsection is a report issued by a United States em12 bassy or consulate relating to the death of a United States 

13 citizen in a foreign country upon receipt by the embassy 

14 or consulate of the foreign death certificate or finding of 

15 death by a local competent authority. 

16 SEC. 3. SURVEILLANCE BY CDC OF DEATHS OF UNITED 

17 STATES CITIZENS ABROAD. 

18 The Public Health Service Act is amended by insert19 ing after section 317T of such Act (42 U.S.C. 247b–22) 

20 the following: 

21 ‘‘SEC. 317U. SURVEILLANCE OF DEATHS OF UNITED STATES 

22 CITIZENS ABROAD. 

23 ‘‘The Secretary, acting through the Director of the 

24 Centers for Disease Control and Prevention, shall expand 

25 and intensify the programs and activities of the Centers 


kjohnson on DSK79L0C42 with BILLS
3 

•HR 2876 IH

1 for surveillance of deaths of United States citizens occur2 ring abroad.’’. 

Æ 


kjohnson on DSK79L0C42 with BILLS
# C_2013377EN.01001901.xml

| 21.12.2013 | EN | Official Journal of the European Union | C 377/19 |
| --- | --- | --- | --- |

21.12.2013

EN

Official Journal of the European Union

C 377/19

---

Action brought on 8 November 2013 — Shire Pharmaceutical Contracts v Commission

(Case T-583/13)

2013/C 377/43

Language of the case: English

Parties

Parties

Applicant: Shire Pharmaceutical Contracts (Hampshire, United Kingdom) (represented by: K. Bacon, Barrister, M. Utges Manley and M. Vickers, Solicitors)

Applicant:

Defendant: European Commission

Defendant:

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | Annul the decision contained in the letter of the European Commission dated 2 September 2013, confirmed by the letter dated 18 October 2013, refusing eligibility for a reward for a voluntary pediatric investigation plan under Article 37 of Regulation (EC) No 1901/2006 (1); and |
| --- | --- |

—

Annul the decision contained in the letter of the European Commission dated 2 September 2013, confirmed by the letter dated 18 October 2013, refusing eligibility for a reward for a voluntary pediatric investigation plan under Article 37 of Regulation (EC) No 1901/2006 (1); and

1

| — | Order the defendant to bear the applicant’s costs. |
| --- | --- |

—

Order the defendant to bear the applicant’s costs.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on two pleas in law.

| 1. | First plea in law, alleging that the contested decision is vitiated by fundamental errors in law in the interpretation of Regulation (EC) No 1901/2006. |
| --- | --- |

1.

First plea in law, alleging that the contested decision is vitiated by fundamental errors in law in the interpretation of Regulation (EC) No 1901/2006.

| 2. | Second plea in law, alleging a breach of the principle of legal certainty. |
| --- | --- |

2.

Second plea in law, alleging a breach of the principle of legal certainty.

---

(1)  Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (OJ 2006 L 378, p. 1)

1

---
# C_2014085EN.01001601.xml

| 22.3.2014 | EN | Official Journal of the European Union | C 85/16 |
| --- | --- | --- | --- |

22.3.2014

EN

Official Journal of the European Union

C 85/16

---

Request for a preliminary ruling from the Conseil d’État (France) lodged on 22 October 2013 — Les Laboratoires Servier SA v Ministre des affaires sociales et de la santé, Ministre de l'Économie et des Finances

(Case C-691/13)

2014/C 85/28

Language of the case: French

Referring court

Referring court

Conseil d’État

Parties to the main proceedings

Parties to the main proceedings

Applicant: Les Laboratoires Servier SA

Applicant:

Defendants: Ministre des affaires sociales et de la santé, Ministre de l’Économie et des Finances

Defendants:

Question referred

Question referred

Does Article 6(2) of Council Directive 89/105/EEC of 21 December 1988 relating to the transparency of measures regulating the prices of medicinal products for human use and their inclusion in the scope of national health insurance systems (1) require that reasons be stated for decisions as to inclusion or re-inclusion in the list of medicinal products eligible for reimbursement by the health insurance funds which — by limiting, in comparison with the application made, the therapeutic indications giving rise to eligibility for reimbursement, or by making that reimbursement subject to conditions relating to, inter alia, the qualifications of the prescribing doctors, the organisation of care or the follow-up of patients, or in any other way — make the reimbursement by the health insurance funds available to only some of the patients liable to benefit from the medicinal product or only in certain circumstances?

1

---

(1)  OJ 1989 L 40, p. 8.

1

---